An Open-Label, Single-Arm, Phase 2 Study of Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma

  • McDonagh, Kevin (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/17/071/31/10